logo
  

Hhgregg Sees Q3 Revenue Drop, Withdraws 2015 EBITDA View - Quick Facts

hhgregg, Inc. (HGG), an appliance, electronics and furniture retailer, Tuesday said it expects third-quarter net sales to be about $666 million, down 6 percent from $707 million reported for the third fiscal quarter of 2014.

On average, 13 analysts polled by Thomson Reuters expect revenues of $670.07 million for the quarter.

Comparable store sales for the quarter are estimated to have decreased about 6 percent, with the appliance category estimated to be relatively flat, the consumer electronics category estimated to have decreased approximately 4 percent.

The home products category is estimated to have decreased approximately 9 percent and and the computer and tablet category is projected to have decreased approximately 35 percent.

The company estimates that its e-commerce business comparable sales were up approximately 59 percent for the fiscal third quarter.

Dennis May, President and CEO, said, "The computer and tablet industry continues to be negatively impacted by declining consumer demand. Additionally, we made a decision not to participate in certain areas of the computer and tablet business that were not profitable."

Further, citing some impairment charges coupled with uncertain current market conditions, the company withdrew its fiscal year 2015 EBITDA outlook.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT